Modulators of endocannabinoid enzymic hydrolysis and membrane transport

Handbook of Experimental Pharmacology

Volumn 168, Issue , 2005, Pages 187-207

  Ho, W S V ^a   Hillard, C J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

2 Arachidonoylglycerol; Anandamide; Carrier; Fatty acid amide hydrolase; Monoacylglycerol lipase; N Arachidonoylethanolamine; Transporter

Indexed keywords

EID: 85099486273     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-26573-2_6     Document Type: Article

References (111)

1. Arreaza G, Deutsch DG (1999) Deletion of a proline-rich region and a transmembrane domain in fatty acid amide hydrolase. FEBS Lett 454:57-60
2. Baker RR, Chang H(2000)Ametabolic path for the degradation of lysophosphatidic acid, an inhibitor of lysophosphatidylcholine lysophospholipase, in neuronal nuclei of cerebral cortex. Biochim Biophys Acta 1483:58-68
3. Balsinde J, Diez E, Mollinedo F (1991) Arachidonic acid release from diacylglycerol in human neutrophils. Translocation of diacylglycerol-deacylating enzyme activities from an intracellular pool to plasma membrane upon cell activation. J Biol Chem 266:15638-15643
4. Beltramo M, Piomelli D (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-Arachidonylglycerol. Neuroreport 11:1231-1235
5. Beltramo M, di Tomaso E, Piomelli D (1997a) Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1- naphthalenyl)-2H-pyran-2-one. FEBS Lett 403:263-267
6. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D (1997b) Functional role of high-Affinity anandamide transport, as revealed by selective inhibition. Science 277:1094-1097
7. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V (1997a) Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272:3315-3323
8. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V (1997b) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-Arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322:671-677
9. Bisogno T, Melck D, De Petrocellis L, Bobrov M, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248:515-522
10. Bisogno T, Melck D, Bobrov M, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V (2000) N-Acyl-dopamines: Novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivationwith cannabimimetic activity in vitro and in vivo. Biochem J 351:817-824
11. Bisogno T, Maccarrone M, De Petrocellis L, Jarrahian A, Finazzi-Agro A, Hillard C, Di Marzo V (2001) The uptake by cells of 2-Arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur J Biochem 268:1982-1989
12. Boger DL, Sato H, Lerner AE, Hedrick MP, Fecik RA, Miyauchi H, Wilkie GD, Austin BJ, Patricelli MP, Cravatt BF (2000) Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide.Proc Natl Acad Sci U S A 97:5044-5049
13. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298:1793-1796
14. Burstein SH, Huang SM, Petros TJ, Rossetti RG, Walker JM, Zurier RB (2002) Regulation of anandamide tissue levels by N-Arachidonylglycine. Biochem Pharmacol 64:1147-1150
15. Cravatt BF, Lichtman AH (2002) The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids 121:135-148
16. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterizationof an enzymethat degrades neuromodulatory fatty-Acid amides.Nature 384:83-87
17. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH(2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98:9371-9376
18. deLago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V (2004) In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. Eur J Pharmacol 484:249-257
19. De Petrocellis L, Melck D, Ueda N, Maurelli S, Kurahashi Y, Yamamoto S, Marino G, Di Marzo V (1997) Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun 231:82-88
20. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483:52-56
21. Desarnaud F, Cadas H, Piomelli D (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270:6030-6035
22. Deutsch DG, Chin SA(1993)Enzymatic synthesisanddegradationof anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796
23. Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A (1997a) Methyl arachidonyl fluorophosphonate: A potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol 53:255-260
24. Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A (1997b) Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun 231:217-221
25. Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N (2001) The cellular uptake of anandamide is coupled to its breakdown by fatty-Acid amide hydrolase. J Biol Chem 276:6967-6973
26. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-Arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264:258-267
27. DiMarzo V, Griffin G, De Petrocellis L, Brandi I, BisognoT, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR (2002) A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. J Pharmacol Exp Ther 300:984-991
28. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819-10824
29. Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ (1998) Synthesis and characterization of diazomethylarachidonyl ketone: An irreversible inhibitor of N-Arachidonylethanolamine amidohydrolase. J Pharmacol Exp Ther 286:184-190
30. Farooqui AA, Horrocks LA (1997) Nitric oxide synthase inhibitors do not attenuate diacylglycerol or monoacylglycerol lipase activities in synaptoneurosomes. Neurochem Res 22:1265-1269
31. Farooqui AA, Anderson DK, Horrocks LA (1993) Effect of glutamate and its analogs on diacylglycerol andmonoacylglycerol lipase activities of neuron-enriched cultures.Brain Res 604:180-184
32. Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS (2001) Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299:332-342
33. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2004) Anandamide transport is independent of fatty-Acid amide hydrolase activity and is blockedby thehydrolysis-resistant inhibitor AM1172.ProcNatlAcad SciUSA101:8756-8761
34. Fernando SR, Pertwee RG (1997) Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist. Br J Pharmacol 121:1716-1720
35. Fowler CJ, Tiger G, Stenstrom A (1997a) Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations.Mode of inhibition and structureactivity relationship. J Pharmacol Exp Ther 283:729-734
36. Fowler CJ, Stenstrom A, Tiger G (1997b) Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol Toxicol 80:103-107
37. Fowler CJ, Holt S, Tiger G (2003) Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependentmanner. J Enzyme InhibMed Chem 18:55-58
38. Fowler CJ, Tiger G, Ligresti A, Lopez-Rodriguez ML, DiMarzo V (2004) Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-A difficult issue to handle. Eur J Pharmacol 492:1-11
39. Gaetani S, Cuomo V, Piomelli D(2003) Anandamide hydrolysis: A new target for anti-Anxiety drugs? Trends Mol Med 9:474-478
40. Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A 94:2238-2242
41. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG(2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci U S A 100:4269-4274
42. Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S (1998) Anandamide amidohydrolase reacting with 2-Arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422:69-73
43. Goparaju SK, Ueda N, Taniguchi K, Yamamoto S (1999) Enzymes of porcine brain hydrolyzing 2-Arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 57:417-423
44. Grazia Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V (2004) A structure-Activity relationship study on N-Arachidonoyl-Amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314:192-196
45. Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agro A, Maccarrone M (2002) Experimental parkinsonism alters endocannabinoid degradation: Implications for striatal glutamatergic transmission. J Neurosci 22:6900-6907
46. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, De Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932-1936
47. Hillard CJ, Jarrahian A (2000) The movement of N-Arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 108:123-134
48. Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: Consensus and controversy. Br J Pharmacol 140:802-808
49. Hillard CJ, Wilkison DM, Edgemond WS, Campbell WB (1995) Characterization of the kinetics and distribution of N-Arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1257:249-256
50. Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-Arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631-638
51. Ho SY, Delgado L, Storch J (2002)Monoacylglycerol metabolism in human intestinal Caco-2 cells: Evidence for metabolic compartmentation and hydrolysis. J Biol Chem 277:1816-1823
52. Holt S, Nilsson J, Omeir R, Tiger G, Fowler CJ (2001) Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. Br J Pharmacol 133:513-520
53. Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, Burstein S, Di Marzo V, Walker JM (2001) Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276:42639-42644
54. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405
55. Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ (2000) Structure-Activity relationships among N-Arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J Neurochem 74:2597-2606
56. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272:27218-27223
57. Karlsson M, Reue K, Xia YR, Lusis AJ, Langin D, Tornqvist H, Holm C (2001) Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene 272:11-18
58. Karttunen P, Saano V, Paronen P, Peura P, Vidgren M(1990) Pharmacokinetics of ibuprofen in man: A single-dose comparison of two over-The-counter, 200 mg preparations. Int J Clin Pharmacol Ther Toxicol 28:251-255
59. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D(2003)Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
60. Konrad RJ, Major CD, Wolf BA (1994) Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: Sequential actions of diacylglycerol and monoacylglycerol lipases. Biochemistry 33:13284-13294
61. Koutek B, Prestwich GD, Howlett AC, Chin SA, Salehani D, Akhavan N, Deutsch DG (1994) Inhibitors of arachidonoyl ethanolamide hydrolysis. J Biol Chem 269:22937-22940
62. Kuriyan J, Cowburn D(1997)Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct 26:259-288
63. Lang W, Qin C, Hill WA, Lin S, Khanolkar AD, Makriyannis A (1996) High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes. Anal Biochem 238:40-45
64. Leggett JD, Aspley S, Beckett SR, D'Antona AM, Kendall DA (2004) Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 141:253-262
65. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302:73-79
66. Lio YC, Reynolds LJ, Balsinde J, Dennis EA (1996) Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta 1302:55-60
67. Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Lastres-Becker I, Gonzalez S, Fernandez-Ruiz J, Ramos JA(2001) Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J Med Chem 44:4505-4508
68. Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, De Lago E, Fernandez-Ruiz J, Ramos JA(2003) Design, synthesis and biological evaluationofnewendocannabinoid transporter inhibitors. Eur J Med Chem 38:403-412
69. Maccarrone M, Salvati S, Bari M, Finazzi A(2000a) Anandamide and 2-Arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biochem Biophys Res Commun 278:576-583
70. Maccarrone M, De Felici M, Bari M, Klinger F, Siracusa G, Finazzi-Agro A (2000b) Downregulation of anandamide hydrolase in mouse uterus by sex hormones. Eur J Biochem 267:2991-2997
71. Maccarrone M, Fiorucci L, Erba F, Bari M, Finazzi-Agro A, Ascoli F (2000c) Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett 468:176-180
72. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A (2001a) Progesterone up-regulates anandamide hydrolase in human lymphocytes: Role of cytokines and implications for fertility. J Immunol 166:7183-7189
73. Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, Di Marzo V, Finazzi-Agro A (2001b) Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch Biochem Biophys 393:321-328
74. Maccarrone M, Bari M, Battista N, Finazzi-Agro A (2002) Estrogen stimulates arachidonoylethanolamide release fromhuman endothelial cells and platelet activation. Blood 100:4040-4048
75. Maccarrone M, Di Rienzo M, Finazzi-Agro A, Rossi A (2003a) Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J Biol Chem 278:13318-13324
76. Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agro A, Rossi A(2003b) Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278:32726-32732
77. Maccarrone M, DeFelici M, Klinger FG, Battista N, Fezza F, Dainese E, Siracusa G, Finazzi-Agro A (2004) Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol Hum Reprod 10:215-221
78. Maurelli S, Bisogno T, De Petrocellis L, Di Luccia A, Marino G, Di Marzo V (1995) Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. FEBS Lett 377:82-86
79. McKinney MK, Cravatt BF (2003) Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase. J Biol Chem278:37393-37399
80. Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z (1997) Anandamide may mediate sleep induction. Nature 389:25-26
81. Mendelson WB, Basile AS (1999) The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport 10:3237-3239
82. Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V (2003) Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65:1473-1481
83. Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ (2003) The general anesthetic propofol increases brain N-Arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol 139:1005-1013
84. Patricelli MP, Cravatt BF (1999) Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry 38:14125-14130
85. Patricelli MP, Cravatt BF (2000) Clarifying the catalytic roles of conserved residues in the amidase signature family. J Biol Chem 275:19177-19184
86. Patricelli MP, Lovato MA, Cravatt BF (1999) Chemical andmutagenic investigations of fatty acid amide hydrolase: Evidence for a family of serine hydrolases with distinct catalytic properties. Biochemistry 38:9804-9812
87. Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie XQ, Makriyannis A (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci U S A 96:5802-5807
88. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301:1020-1024
89. Pratt PF, Hillard CJ, Edgemond WS, Campbell WB (1998) N-Arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 274:H375-381
90. Puffenbarger RA, Kapulina O, Howell JM, Deutsch DG (2001) Characterization of the 5'-sequence of the mouse fatty acid amide hydrolase. Neurosci Lett 314:21-24
91. Riendeau D, Guay J, Weech PK LF, Yergey J, Li C, Desmarais S, Perrier H, Liu S, Nicoll-Griffith D, et al (1994) Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 269:15619-15624
92. Rodriguez De Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D (2001) An anorexic lipid mediator regulated by feeding. Nature 414:209-212
93. Ronesi J, Gerdeman GL, Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-Termdepression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24:1673-1679
94. Ruiz-Llorente L, Ortega-Gutierrez S, Viso A, Sanchez MG, Sanchez AM, Fernandez C, Ramos JA, Hillard C, Lasuncion MA, Lopez-Rodriguez ML, Diaz-Laviada I (2004) Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study. Br J Pharmacol 141:457-467
95. Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R (2004) Monoglyceride lipaselike enzymatic activity is responsible for hydrolysis of 2-Arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 67:1381-1387
96. Sakurada T, Noma A (1981) Subcellular localization and some properties of monoacylglycerol lipase in rat adipocytes. J Biochem (Tokyo) 90:1413-1419
97. Shrestha R, Dixon RA, Chapman KD (2003) Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis thaliana. J Biol Chem 278:34990-34997
98. Somma-Delpero C, Valette A, Lepetit-Thevenin J, Nobili O, Boyer J, Verine A (1995) Purification and properties of a monoacylglycerol lipase in human erythrocytes. Biochem J 312:519-525
99. Street I, Lin H, Laliberte F, Ghomashchi F, Wang Z, Perrier H, Tremblay N, Huang Z, Weech P, Gelb M(1993) Slow-And tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 32:5935-5940
100. Tarzia G, Duranti A, Tontini A, Piersanti G, Mor M, Rivara S, Plazzi PV, Park C, Kathuria S, Piomelli D (2003) Design, synthesis, and structure-Activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. JMed Chem 46:2352-2360
101. Thomas EA, Cravatt BF, Danielson PE, Gilula NB, Sutcliffe JG (1997) Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res 50:1047-1052
102. Tornqvist H, Belfrage P (1976) Purification and some properties of a monoacylglycerolhydrolyzing enzyme of rat adipose tissue. J Biol Chem 251:813-819
103. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254:137-140
104. Ueda N, Kurahashi Y, Yamamoto S, Tokunaga T (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem 270:23823-23827
105. Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG (2000) The fatty acid amide hydrolase (FAAH). Chem Phys Lipids 108:107-121
106. Valenti M, Vigano D, Casico MG, Rubino T, Steardo L, Parolaro D, Di Marzo V (2004) Differential diurnal variations of anandamide and 2-Arachidonoyl- glycerol levels in rat brain. Cell Mol Life Sci 61:945-950
107. Vyvoda OS, Rowe CE (1973) Glyceride lipases in nerve endings of guinea-pig brain and their stimulation by noradrenaline, 5-hydroxytryptamine and adrenaline. Biochem J 132:233-248
108. Waleh NS, Cravatt BF, Apte-Deshpande A TA, Kilduff TS (2002) Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene 291:203-210
109. Witting A, Walter L, Wacker J, Moller T, Stella N (2004) P2X7 receptors control 2-Arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci U S A 101:3214-3219
110. Xiao AZ, Zhao YG, Duan EK (2002) Expression and regulation of the fatty acid amide hydrolase gene in the rat uterus during the estrous cycle and peri-implantation period. Mol Hum Reprod 8:651-658
111. Yazulla S, Studholme KM, McIntosh HH, Deutsch DG (1999) Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. J Comp Neurol 415:80-90